Aptose Biosciences Management
Management criteria checks 3/4
Aptose Biosciences' CEO is William Rice, appointed in Oct 2013, has a tenure of 10.75 years. total yearly compensation is $924.67K, comprised of 67.4% salary and 32.6% bonuses, including company stock and options. directly owns 0.16% of the company’s shares, worth CA$37.64K. The average tenure of the management team and the board of directors is 2.1 years and 10.8 years respectively.
Key information
William Rice
Chief executive officer
US$924.7k
Total compensation
| CEO salary percentage | 67.4% |
| CEO tenure | 10.8yrs |
| CEO ownership | 0.2% |
| Management average tenure | 2.1yrs |
| Board average tenure | 10.8yrs |
Recent management updates
Recent updates
Here's Why We're Watching Aptose Biosciences' (TSE:APS) Cash Burn Situation
Mar 26
We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate
Dec 08We're Keeping An Eye On Aptose Biosciences' (TSE:APS) Cash Burn Rate
Aug 05We Think Aptose Biosciences (TSE:APS) Needs To Drive Business Growth Carefully
Apr 02Companies Like Aptose Biosciences (TSE:APS) Are In A Position To Invest In Growth
Sep 30Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling
Feb 07
Is Aptose Biosciences Inc.'s (TSE:APS) Shareholder Ownership Skewed Towards Insiders?
Jan 03We're Not Very Worried About Aptose Biosciences' (TSE:APS) Cash Burn Rate
Nov 29Jotin Marango Is The Senior VP & Chief Business Officer of Aptose Biosciences Inc. (TSE:APS) And They Just Sold 26% Of Their Shares
Jul 11Aptose Biosciences Inc. (TSE:APS) Insiders Have Been Selling
Jun 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$47m |
| Dec 31 2023 | US$925k | US$623k | -US$51m |
| Sep 30 2023 | n/a | n/a | -US$49m |
| Jun 30 2023 | n/a | n/a | -US$48m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$2m | US$599k | -US$42m |
| Sep 30 2022 | n/a | n/a | -US$56m |
| Jun 30 2022 | n/a | n/a | -US$58m |
| Mar 31 2022 | n/a | n/a | -US$61m |
| Dec 31 2021 | US$2m | US$582k | -US$65m |
| Sep 30 2021 | n/a | n/a | -US$56m |
| Jun 30 2021 | n/a | n/a | -US$58m |
| Mar 31 2021 | n/a | n/a | -US$60m |
| Dec 31 2020 | US$12m | US$582k | -US$55m |
| Sep 30 2020 | n/a | n/a | -US$48m |
| Jun 30 2020 | n/a | n/a | -US$42m |
| Mar 31 2020 | n/a | n/a | -US$32m |
| Dec 31 2019 | US$2m | US$562k | -US$26m |
| Sep 30 2019 | n/a | n/a | -US$25m |
| Jun 30 2019 | n/a | n/a | -US$24m |
| Mar 31 2019 | n/a | n/a | -US$28m |
| Dec 31 2018 | US$2m | US$540k | -US$29m |
| Sep 30 2018 | n/a | n/a | -US$26m |
| Jun 30 2018 | n/a | n/a | -US$23m |
| Mar 31 2018 | n/a | n/a | -US$15m |
| Dec 31 2017 | US$983k | US$520k | -US$12m |
Compensation vs Market: William's total compensation ($USD924.67K) is above average for companies of similar size in the Canadian market ($USD176.35K).
Compensation vs Earnings: William's compensation has been consistent with company performance over the past year.
CEO
William Rice (65 yo)
10.8yrs
Tenure
US$924,668
Compensation
Dr. William G. Rice, Ph D., had served as an Independent Director of Oncolytics Biotech Inc. since June 08, 2015 until June 30, 2021. He has been the Chief Executive Officer and President of Aptose Bioscie...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 10.8yrs | US$924.67k | 0.16% $ 37.6k | |
| Senior VP | 2.1yrs | US$611.37k | 0.033% $ 8.1k | |
| Senior VP & Chief Medical Officer | 4.5yrs | US$750.08k | 0.033% $ 8.1k | |
| Senior Vice President of Regulatory Affairs | less than a year | no data | no data | |
| VP & Controller | 1.4yrs | no data | no data |
2.1yrs
Average Tenure
61yo
Average Age
Experienced Management: APS's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 10.8yrs | US$924.67k | 0.16% $ 37.6k | |
| Independent Director | 16.8yrs | US$127.68k | 0.0020% $ 476.0 | |
| Independent Director | 1.8yrs | US$132.17k | 0.077% $ 18.7k | |
| Lead Independent Director | 16.8yrs | US$172.17k | 0.0066% $ 1.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.6yrs | US$123.67k | 0.15% $ 37.0k | |
| Independent Director | 13.3yrs | US$122.68k | 0.0046% $ 1.1k | |
| Chairman of Scientific Advisory Board | 10.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 9.3yrs | no data | no data | |
| Independent Director | 5.9yrs | US$123.67k | 0.0073% $ 1.8k |
10.8yrs
Average Tenure
71.5yo
Average Age
Experienced Board: APS's board of directors are seasoned and experienced ( 10.8 years average tenure).